Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

被引：266

作者：

Kristensen, Steen D. ^{[1
]}

Laut, Kristina G. ^{[1
]}

Fajadet, Jean ^{[2
]}

Kaifoszova, Zuzana ^{[3
]}

Kala, Petr ^{[4
,5
]}

Di Mario, Carlo ^{[6
]}

Wijns, William ^{[7
]}

Clemmensen, Peter ^{[8
]}

Agladze, Vaja ^{[9
]}

Antoniades, Loizos ^{[10
]}

Alhabib, Khalid F. ^{[11
]}

De Boer, Menko-Jan ^{[12
]}

Claeys, Marc J. ^{[13
]}

Deleanu, Dan ^{[14
]}

Dudek, Dariusz ^{[15
]}

Erglis, Andrejs ^{[16
]}

Gilard, Martine ^{[17
]}

Goktekin, Omar ^{[18
]}

Guagliumi, Giulio ^{[19
]}

Gudnason, Thorarinn ^{[20
,21
]}

Hansen, Kim Wadt ^{[22
]}

Huber, Kurt ^{[23
]}

James, Stefan ^{[24
,25
]}

Janota, Tomas ^{[26
]}

Jennings, Siobhan ^{[27
]}

Kajander, Olli ^{[28
]}

Kanakakis, John ^{[29
]}

Karamfiloff, Kiril K. ^{[30
]}

Kedev, Sasko ^{[31
]}

Kornowski, Ran ^{[32
]}

Ludman, Peter F. ^{[33
]}

Merkely, Bela ^{[34
]}

Milicic, Davor ^{[35
]}

Najafov, Ruslan ^{[36
]}

Nicolini, Francesca A. ^{[37
]}

Noc, Marko ^{[38
]}

Ostojic, Miodrag ^{[39
]}

Pereira, Helder ^{[40
]}

Radovanovic, Dragana ^{[41
]}

Sabate, Manel ^{[42
]}

Sobhy, Mohamed ^{[43
]}

Sokolov, Maxim ^{[44
]}

Studencan, Martin ^{[45
]}

Terzic, Ibrahim ^{[46
]}

Wahler, Steffen ^{[47
]}

Widimsky, Petr ^{[48
]}

机构：

[1] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark

[2] Clin Pasteur, Toulouse, France

[3] European Heart House, EAPCI, Nice, France

[4] Masaryk Univ, Dept Internal Cardiovasc Med, Brno, Czech Republic

[5] Univ Hosp Brno, Brno, Czech Republic

[6] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6LY, England

[7] Onze Lieve Vrouw Hosp, Cardiovasc Ctr Aalst, Aalst, Belgium

[8] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark

[9] SFL Contact Person Geogia, GE-0105 Tbilisi, Georgia

[10] Larnaca Gen Hosp, Dept Cardiol, Larnax, Cyprus

[11] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh 11461, Saudi Arabia

[12] Hearth Lung Ctr, UMC St Radboud Nijmegen, Dept Cardiol, Nijmegen, Netherlands

[13] Univ Antwerp Hosp, Dept Cardiol, Antwerp, Belgium

[14] Cardiovasc Dis Inst CC Iliescu, Bucharest, Romania

[15] Jagiellonian Univ, Univ Hosp, Dept Cardiol & Cardiovasc Intervent, Krakow, Poland

[16] Univ Latvia, Pauls Stradins Clin Univ Hosp, Riga, Latvia

[17] CHRU La Cavale Blance, Dept Cardiol, Brest, France

[18] Bezmialem Vakif Univ, Fac Med, Dept Cardiol, Istanbul, Turkey

[19] Osped Riuniti Bergamo, Cardiovasc Dept, Div Cardiol, I-24100 Bergamo, Italy

[20] Univ Hosp Iceland, Landspitali, Dept Cardiol, Reykjavik, Iceland

[21] Univ Hosp Iceland, Landspitali, Cardiovasc Res Ctr, Reykjavik, Iceland

[22] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark

[23] Wilhelminen Hosp, Dept Internal Med Cardiol & Emergency Med 3, Vienna, Austria

[24] Uppsala Univ, Dept Cardiol, Uppsala, Sweden

[25] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden

[26] Charles Univ Prague, Sch Med 1, Univ Hosp, Prague, Czech Republic

[27] Hlth Serv Execut, Dept Publ Hlth, Dublin, Ireland

[28] Tampere Univ Hosp, Heart Ctr Co, Tampere, Finland

[29] Univ Athens, Dept Clin Therapeut, Alexandra Hosp, Athens, Greece

[30] Univ Hosp St Ekaterina, Dept Cardiol, Sofia, Bulgaria

[31] Univ St Cyril & Methodius, Dept Intervent Cardiol, Univ Clin Cardiol, Skopje, Macedonia

[32] Tel Aviv Univ, Petach Tikva & Sackler Fac Med, Belinson & Hasharon Hosp, Dept Cardiol, IL-69978 Tel Aviv, Israel

[33] Univ Hosp Birmingham, NHS Fdn, Dept Cardiol, Birmingham, W Midlands, England

[34] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary

[35] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Cardiovasc Dis, Zagreb 41001, Croatia

[36] Cardiol Res Inst, Myocardial Infarction Dept, Baku, Azerbaijan

[37] Osped Stato, Dept Internal Med, Div Cardiol, San Marino, CA USA

[38] Univ Med Ctr, Ljubljana, Slovenia

[39] Clin Ctr Serbia, Inst Cardiovasc Dis, Dept Cardiol, Belgrade, Serbia

[40] Portugese Soc Cardiol, Assoc Cardiovasc Intervent, SFL,Portugal Champ, Lisbon, Portugal

[41] Univ Zurich, Inst Social & Prevent Med, AMIS Plus Data Ctr, CH-8006 Zurich, Switzerland

[42] Hosp Clin Barcelona, Clin Thorax Inst, Dept Cardiol, Barcelona, Spain

[43] Univ Alexandria, Fac Med, SFL Egypt Champ, Alexandria, Egypt

[44] Ukraine Acad Med Sci, MD Strazhesko Inst Cardiol, Natl Sci Ctr, Kiev, Ukraine

[45] Univ Hosp JA Reiman, Cardiac Ctr, Presov, Slovakia

[46] BH Heart Ctr Tuzla, Tuzla, Bosnia & Herceg

[47] Med Sch Hamburg, Dept Hlth Econ, Hamburg, Germany

[48] Charles Univ Prague, Fac Med 3, Cardio Ctr, Prague, Czech Republic

来源：

EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 29期

关键词：

Primary percutaneous coronary intervention; STEMI; Treatment variation; Europe; PERCUTANEOUS CORONARY INTERVENTION; BASE-LINE CHARACTERISTICS; PRIMARY ANGIOPLASTY; MANAGEMENT-PRACTICES; HOSPITAL OUTCOMES; GLOBAL REGISTRY; HEART-DISEASE; SYSTEM DELAY; MORTALITY; GUIDELINES;

D O I：

10.1093/eurheartj/eht529

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.

引用

页码：1957 / 1970

页数：14

共 48 条

[21] Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
Keeley, EC
Boura, JA
Grines, CL
[J]. LANCET, 2003, 361 (9351) : 13 - 20
[22] Kristensen SD, 2012, EUROINTERVENTION, V8, P35, DOI [10.4244/EIJV8SPA5, 10.4244/EIJV8I1A7]
[23] 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Kushner, Frederick G.
Smith, Sidney C.
King, Spencer B.
Anderson, Jeffrey L.
Antman, Elliott M.
Bailey, Steven R.
Bates, Eric R.
Blankenship, James C.
Casey, Donald E.
Green, Lee A.
Hochman, Judith S.
Jacobs, Alice K.
Krumholz, Harlan M.
Morrison, Douglass A.
Ornato, Joseph P.
Pearle, David L.
Peterson, Eric D.
Sloan, Michael A.
Whitlow, Patrick L.
Williams, David O.
[J]. CIRCULATION, 2009, 120 (22) : 2271 - 2306
[24] Regional system of care for ST-segment elevation myocardial infarction in the Northern Alps: A controlled pre- and postintervention study
Labarere, Jose
Belle, Loic
Fourny, Magali
Vanzetto, Gerald
Debaty, Guillaume
Delgado, David
Brallet, Julien
Vallet, Benoit
Danchin, Nicolas
[J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (8-9) : 414 - 423
[25] Timely and optimal treatment of patients with STEMI
Lassen, Jens F.
Botker, Hans E.
Terkelsen, Christian J.
[J]. NATURE REVIEWS CARDIOLOGY, 2013, 10 (01) : 41 - 48
[26] Laut KG, 2011, EUR CARDIOL REV, V7, P108, DOI [10.15420/ecr.2011.7.2.108., DOI 10.15420/ECR.2011.7.2.108]
[27] Laut KG, 2013, EUROINTERVENTION, V9, P469, DOI 10.4244/EIJV9I4A76
[28] Determinants and patterns of utilization of primary percutaneous coronary intervention across 12 European countries: 2003-2008
Laut, Kristina Gronborg
Gale, Christopher Peter
Lash, Timothy L.
Kristensen, Steen Dalby
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2745 - 2753
[29] McLenachan James M, 2012, EuroIntervention, V8 Suppl P, pP99, DOI 10.4244/EIJV8SPA18
[30] Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI
McManus, David D.
Gore, Joel
Yarzebski, Jorge
Spencer, Frederick
Lessard, Darleen
Goldberg, Robert J.
[J]. AMERICAN JOURNAL OF MEDICINE, 2011, 124 (01) : 40 - 47

← 1 2 3 4 5 →